Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05602610 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Prognostic Score to Predict Relapse in VL

Study acronym: CPS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv5
  2. Start date changed from estimate of Mar 1, 2023 to Feb 3, 2023v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jan 1, 2023 to Mar 1, 2023
    • Study sites: 0 to 1
    v3
  4. Study description expanded, about 1 wordv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective cohort study has the aim to develop a prognostic tool to predict relapse in patients suffering from visceral leishmaniasis (VL) from VL endemic regions in Ethiopia. Therefore, comprehensive clinical and laboratory characterization of all confirmed VL patients before and during treatment will be performed in order to identify the factors that determine prognosis of the patients. This approach would result in more efficient patient care and would reduce the case fatality and morbidity, and improve follow-up and care for those at risk of VL relapse.
Trial Details
NCT Number NCT05602610
Lead Sponsor Institute of Tropical Medicine, Belgium
Collaborators: University of Gondar
Conditions
(from sponsor)		 Visceral Leishmaniasis
Related terms Leishmaniasis, Leishmaniasis, Visceral, Recurrence
Enrollment 741 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov